Edward J. Fiorentino
Executive Chairman
Ed Fiorentino serves as executive chairman of TerSera Therapeutics. Previously, he was TerSera’s chairman and chief executive officer from the company’s inception in 2016 through December 2023. Prior to TerSera, Ed was chairman and CEO of Crealta Pharmaceuticals, and CEO of Actient Pharmaceuticals.
Prior to Crealta and Actient, Ed was with Abbott for more than 20 years. His senior-level management experience at Abbott includes Corporate Vice President of pharmaceutical commercial operations; Senior Vice President and President of Abbott Diabetes Care; and Executive Vice President of TAP Pharmaceuticals, an Abbott joint venture with Takeda Pharmaceuticals. Ed began his career with Bristol-Myers.
Ed currently serves on the boards of TerSera Therapeutics, Senseonics, Clearbrook, and the Aquinas Institute. He previously served on the boards of Crealta Pharmaceuticals, Actient Pharmaceuticals, TAP Pharmaceuticals, Graceway Pharmaceuticals, iBIO, California Healthcare Institute, National Pharmaceutical Council, and Allendale Association.
Ed holds a BS in Business Administration from the State University of New York and an MBA from Syracuse University.
